why choose us

First received: February 19, 2024

Clinical Trial: Late Effects and HRQoL in Survivors of Allo-HSCT - a Cross Sectional Study

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hematological Diseases

Study Type: OBSERVATIONAL


Official Title: Late Effects and Health-Related Quality of Life in Survivors of Allogeneic Hematopoietic - a Cross-sectional Study

Brief Summary: The cross-sectional study aims to describe the burden of late effects and survivorship-specific health-related quality of life in a nationwide cohort of patients treated with allo-HSCT in Denmark.Further, identify demographic, medical or personal factors associated with better self-reported health and quality of life.

Read more